| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/17/2003 | WO2003057240A2 Treatment and diagnosis of af4-dependant diseases |
| 07/17/2003 | WO2003057239A1 Polyphenol inhibition of nucleoside diphosphate kinase-b activity and cancer metastasis |
| 07/17/2003 | WO2003057237A1 Use of interleukin-6 for treatment of obesity |
| 07/17/2003 | WO2003057236A1 Body weight gain inhibitor |
| 07/17/2003 | WO2003057235A2 Modification of feeding behavior |
| 07/17/2003 | WO2003057233A1 Composition for preventing or treating mastitis of dairy cattle |
| 07/17/2003 | WO2003057223A1 Method of treating sexual dysfunctions with delta opioid receptor agonist compounds |
| 07/17/2003 | WO2003057206A1 Pyruvate cardioplegia solutions for administration to the heart during cardiopulmonary surgery and methods of use thereof |
| 07/17/2003 | WO2003057203A2 Biomaterials based on hyaluronic acid for the anti-angiogenic therapy in the treatment of tumours |
| 07/17/2003 | WO2003057200A2 Compositions comprising inhibitors of dpp-iv and nep enzymes for the treatment of diabetes |
| 07/17/2003 | WO2003057179A2 Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes |
| 07/17/2003 | WO2003057170A2 Oral insulin therapy |
| 07/17/2003 | WO2003057168A2 Cancer-associated epitope |
| 07/17/2003 | WO2003057158A2 Method of treating apoptosis and compositions thereof |
| 07/17/2003 | WO2003057152A2 Hair follicle growth |
| 07/17/2003 | WO2003057144A2 Change inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | WO2003057142A2 Antisense modulation of macrophage inflammatory protein 3-alpha expression |
| 07/17/2003 | WO2003057134A2 Specific binding agents of human angiopoietin-2 |
| 07/17/2003 | WO2003057012A2 S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer |
| 07/17/2003 | WO2003057007A2 System for monitoring bacterial tumor treatment |
| 07/17/2003 | WO2003056925A1 Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex |
| 07/17/2003 | WO2003056913A1 Nonhuman model animal lacking the ability to control lymphocyte migration |
| 07/17/2003 | WO2003056909A2 Hair removal and animal husbandry method |
| 07/17/2003 | WO2003056897A2 Highly phosphorylated acid beta-glucocerebrosidase and methods of treating gaucher's disease |
| 07/17/2003 | WO2003048119A3 Method of producing n-[(2s)-sulfanyl-4-(1,5,5-trimethylhydantoinyl)butanoyl]-l-leucyl-l-tert-leucine n-methylamide and intermediate thereof |
| 07/17/2003 | WO2003047507A3 Factor viii c2 domain variants |
| 07/17/2003 | WO2003038057A3 Genetic vaccine against human immunodeficiency virus |
| 07/17/2003 | WO2003037273A3 Method of use of erythropoietin to treat ischemic acute renal failure |
| 07/17/2003 | WO2003031595A3 Molecules for disease detection and treatment |
| 07/17/2003 | WO2003030827A3 Compositions for and methods of treating and preventing sirs/sepsis |
| 07/17/2003 | WO2003026641A8 Modulation of stat activity |
| 07/17/2003 | WO2003025197A3 Mutant sh3-binding protein compositions and methods |
| 07/17/2003 | WO2003020371A3 Potentiator composition comprising a terpene for enhancing a therapeutical effect of antitumoral agents in the treatment of cancer |
| 07/17/2003 | WO2003020325A3 Methods for sterilizing preparations containing albumin |
| 07/17/2003 | WO2003008573A3 Silencing of gene expression by sirna |
| 07/17/2003 | WO2003004595A3 Materials and methods relating to protein and nucleic acid evolution |
| 07/17/2003 | WO2003000896A3 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE |
| 07/17/2003 | WO2002090566A3 Recombinant tumor specific antibody and use thereof |
| 07/17/2003 | WO2002083928A3 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer |
| 07/17/2003 | WO2002081684A3 Antisense calpain nucleotides and uses thereof |
| 07/17/2003 | WO2002081646A3 Epitope sequences |
| 07/17/2003 | WO2002072626A3 Novel form of the phgpx protein as a diagnostic marker for male infertility |
| 07/17/2003 | WO2002059286A3 Adenylate cyclases |
| 07/17/2003 | WO2002058589A3 Agents and methods for promoting bone growth |
| 07/17/2003 | WO2002058323A3 Method for identifying modulators of bace |
| 07/17/2003 | WO2002057450A3 Proteins and nucleic acids encoding same |
| 07/17/2003 | WO2002055693A3 Method for inhibiting the expression of a target gene |
| 07/17/2003 | WO2002049663A3 Compositions and methods for manipulating glial progenitor cells and treating neurological deficits |
| 07/17/2003 | WO2002043747A3 Modulation of cell growth by inhibiting binding of kringle 2 domain of plasminogen |
| 07/17/2003 | WO2002040715A3 Molecules for disease detection and treatment |
| 07/17/2003 | WO2002039947A3 Carrier vectors through an epithelium with tight junctions |
| 07/17/2003 | WO2002029060A9 Hematopoietin receptors hpr1 and hpr2 |
| 07/17/2003 | WO2002026998A3 Hydrolases |
| 07/17/2003 | WO2002022805A3 Modulation of il-2- and il-15-mediated t cell responses |
| 07/17/2003 | WO2002022660A3 Novel nucleic acids and polypeptides |
| 07/17/2003 | WO2002011713A3 Methods of treating bone cancer and the pain associated therewith using endothelin antagonists |
| 07/17/2003 | WO2002006479A3 Apoptosis-inducing dna sequences |
| 07/17/2003 | WO2002000171A3 Composition for delivery of hematopoietic growth factor |
| 07/17/2003 | WO2001064869A9 Tumor-related antigen |
| 07/17/2003 | WO2001062891A3 207 human secreted proteins |
| 07/17/2003 | US20030135873 Transgenic animal model coding fusion protein comprising nuclear protein and herpes viral vp16 protein; antidiabetic agents; uncoupling proteins |
| 07/17/2003 | US20030135196 Irrigating via the flow pathway the area of the hemorrhage with a synthetic cerebrospinal fluid to reduce an indication of the presence of blood in effluent from the outflow catheter. |
| 07/17/2003 | US20030135036 Platelet glycoprotein v gene and uses |
| 07/17/2003 | US20030135035 Human ZZAP1 protein |
| 07/17/2003 | US20030135034 Nucleotide sequences coding extracellular membrane proteins; antitumor agents; antiproliferative agents; antiiiflammatory agents; enterotoxins; neuroprotectants |
| 07/17/2003 | US20030135029 Tumour necrosis factor binding ligands |
| 07/17/2003 | US20030135028 Human serine protease and serpin polypeptides |
| 07/17/2003 | US20030135026 Compounds and methods for diagnosis of tuberculosis |
| 07/17/2003 | US20030135025 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134889 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 07/17/2003 | US20030134882 Use of C2-substituted indan-1-one systems for preparing medicaments for the prophylaxis or treatment of obesity |
| 07/17/2003 | US20030134881 Substituted with a thio, sulfoxy or sulfonyl group |
| 07/17/2003 | US20030134856 Method and structure for inhibiting activity of serine elastases |
| 07/17/2003 | US20030134819 Recombinant bacterial cells for delivery of PNP to tumor cells |
| 07/17/2003 | US20030134814 Isolated nucleic acids molecules, designated 18080 nucleic acid molecules, which encode serine carboxypeptidase members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 18080 nucleic acid |
| 07/17/2003 | US20030134810 Delivery of pharmacologically active agents associated with polymeric biocompatible materials. Compositions comprising a first, negatively charged pharmacologically active agent such as an oligonucleotide and a polycationic polymer such as |
| 07/17/2003 | US20030134809 Modulating the expression of ABC transporter MHC 1. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding ABC transporter MHC 1. Methods of using these compounds for |
| 07/17/2003 | US20030134806 Method and reagent for the inhibition of grid |
| 07/17/2003 | US20030134802 Novel effectors of dipepetidyl peptidase IV |
| 07/17/2003 | US20030134801 Pharmaceutical compositions containing them are of the class of thrombin inhibitors which are useful as anticoagulants. |
| 07/17/2003 | US20030134800 Physiologically active substance in high content, suppressing the initial excess release, and achieving a stable release speed over a long period of time is provided. composition weight, (2) hydroxynaphthoic acid |
| 07/17/2003 | US20030134799 Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function |
| 07/17/2003 | US20030134798 Protection and enhancement of erythropoietin-responsive cells, tissues and organs |
| 07/17/2003 | US20030134797 Intestinal trefoil factors and nucleic acids encoding intestinal trefoil factors are disclosed. The intestinal trefoil factors disclosed are resistant to destruction in the digestive tract and can be used for the treatment of peptic |
| 07/17/2003 | US20030134796 Antithrombin for the prevention and therapy of vasculoproliferative disorders |
| 07/17/2003 | US20030134795 New subcutaneous injection dosing regimen for erythropoietin to treat anemia. The new erythropoietin treatment regimen of the present invention results in improved hemoglobin levels with less frequent dosing. |
| 07/17/2003 | US20030134792 Compositions and methods for treating articular cartilage disorders |
| 07/17/2003 | US20030134791 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134790 Administering to a patient a composition that inhibits bone morphogenetic protein-2 activity and/or bone morphogenetic protein-4 activity. Such inhibition may be accomplished by ligands or antibodies that bind to BMP-2 and/or BMP-4 or |
| 07/17/2003 | US20030134789 Compositions and methods for protecting tissues and cells from damage, and for repairing damaged tissues |
| 07/17/2003 | US20030134788 Human tumor necrosis factor receptor TR16 |
| 07/17/2003 | US20030134786 Compositions for the prevention or amelioration of symptoms of anthrax. In particular, the present invention relates to TANGO 197 and/or TANGO 216 fusion polypeptides and their use as part of such methods. |
| 07/17/2003 | US20030134785 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134782 Product R, a novel therapeutic composition for treating viral infections and stimulating the immune system, comprises a unique peptide having 31 amino acids and unique peptide having 21 amino acids and connected with an oligo-nucleotide through |
| 07/17/2003 | US20030134781 Topical application of compositions to skin in need thereof, where the compositions comprise at least one peptide copper complex, or at least one peptide copper complex in combination with retinol, at least one retinol derivative, or a mixture. |
| 07/17/2003 | US20030134780 Skin care compositions containing peptide copper complexes and retinol, retinol derivatives, or a mixture thereof |
| 07/17/2003 | US20030134779 Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections |
| 07/17/2003 | US20030134778 Pharmaceutical composition comprising factor VIII and neutral liposomes |
| 07/17/2003 | US20030134777 Treating or preventing arrhythmias in a human subject comprising the administration of an effective amount of a calcium/calmodulin-dependent protein kinase inhibitor. Also provided are pharmaceutical compositions as antiarrhythmia |
| 07/17/2003 | US20030134774 Inhibiting the onset of a cardiac disorder in a subject afflicted with cardiac hypertrophy, (2) reducing the activity of PKC- delta or PKC- epsilon present in cardiomyocytes of a subject afflicted with cardiac hypertrophy, and (3) reducing |